KATRINA TRAVERSO: Open Payments
NPI 1346535929 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 29 payments from 15 companies in 2025. Trend: 2023 $887 · 2024 $567 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 3 | $129 |
| Valinor Pharma, LLC | 5 | $75 |
| Boston Scientific Corporation | 2 | $67 |
| Forte Bio-Pharma LLC | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| SPR Therapeutics, Inc | 1 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $36 |
Products named: Evoke, MOVANTIK, PROLATE, HORIZANT, SPRINT PNS System, CAPLYTA, Belbuca, General - Therapies.
Industry payments across NC — which companies pay providers there.
